How Much Does Vardenafil (Levitra/Staxyn) Cost in Montana in 2026?

Montana Retail Pricing for Vardenafil in 2026

The average cash price for generic vardenafil at Montana retail pharmacies sits around $120 per month in 2026. Brand-name Levitra carries a manufacturer list price near $350 per month from Bayer, though very few patients pay that figure out of pocket because generic alternatives have been available since 2018.

Price variation across Montana is real. Pharmacies in Billings, Missoula, and Great Falls tend to cluster near the $120 average, while rural independents may charge $90 to $150 depending on their wholesale agreements. The oral disintegrating tablet form, Staxyn, typically costs more than standard vardenafil tablets because it lacks a generic equivalent as of early 2026.

Vardenafil received FDA approval in 2003 as the second PDE5 inhibitor after sildenafil. The key registration trial by Porst et al. (2003) demonstrated that vardenafil 20 mg improved erectile function domain scores by 7.7 points over placebo on the IIEF questionnaire, with 80% of intercourse attempts rated as successful at the 20 mg dose. That efficacy profile remains the pharmacological basis for its continued use two decades later.

A price-per-dose comparison often matters more than monthly cost. Most men use vardenafil on demand rather than daily, so a man using it twice per week pays roughly half the monthly figure compared to someone using it four times per week. Asking your pharmacist to quote a per-tablet price, not just a 30-count bottle price, gives a clearer picture of actual out-of-pocket spending.

Montana Medicaid Does Not Cover Vardenafil

Montana Medicaid does not cover vardenafil or any PDE5 inhibitor for erectile dysfunction. This mirrors federal precedent. The Deficit Reduction Act of 2005 gave states explicit authority to exclude ED drugs from Medicaid formularies, and Montana exercises that exclusion.

Men enrolled in Montana Medicaid who need ED treatment have limited pharmacological options through the program. Some urologists pursue prior authorization for PDE5 inhibitors when ED stems from a documented medical cause such as radical prostatectomy, spinal cord injury, or diabetes-related neuropathy, but approvals under these carve-outs are uncommon and require substantial clinical documentation.

The American Urological Association (AUA) guideline on ED (2018) recommends PDE5 inhibitors as first-line pharmacotherapy. Despite this guideline status, Medicaid programs in 44 states, Montana included, either exclude or heavily restrict PDE5 inhibitor coverage. For Montana Medicaid beneficiaries, cash-pay generics or 503A compounded alternatives are often the most accessible route.

One workaround: Montana's Medicaid Expansion population (adults earning up to 138% of the federal poverty level) may qualify for manufacturer savings programs that reduce generic vardenafil to $0 to $30 per fill, though eligibility depends on the specific program's income thresholds.

Insurance Coverage for Vardenafil in Montana

Private insurance coverage for vardenafil in Montana varies by plan and tier. Most large-group employer plans through Blue Cross Blue Shield of Montana, Allegiance, and PacificSource place generic vardenafil on Tier 2 or Tier 3, with copays ranging from $25 to $75 per fill. Quantity limits are standard. Six to eight tablets per month is the typical ceiling.

Self-funded employer plans have no state mandate requiring ED drug coverage, so some exclude PDE5 inhibitors entirely. Checking your plan's formulary before filling the prescription avoids surprise costs.

Medicare Part D plans in Montana generally cover generic vardenafil, but again with quantity limits. The Centers for Medicare & Medicaid Services (CMS) reversed the Part D ED drug exclusion in 2006, and most Part D formularies now include at least one generic PDE5 inhibitor. Copays for vardenafil under Part D Tier 2 placement average $20 to $45 per fill in Montana for 2026.

Montana Health Co-op, the state's ACA marketplace insurer for many counties, lists generic vardenafil on its 2026 formulary with a Tier 3 copay. Men purchasing individual market plans should verify formulary status during open enrollment rather than assuming coverage, because marketplace formularies shift annually.

A step-therapy requirement is common across Montana insurers. Many plans require a trial of sildenafil (the cheapest generic PDE5 inhibitor) before approving vardenafil. If sildenafil causes side effects like visual disturbance or flushing, a documented trial-and-failure letter from your prescriber usually satisfies the step-therapy override.

Compounded Vardenafil in Montana: Legal and Available

Compounded vardenafil is legal in Montana through licensed 503A pharmacies. These compounding pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription.

Montana does not impose additional state-level restrictions beyond federal 503A requirements. A prescriber writes a prescription, and a licensed 503A pharmacy compounds vardenafil in a customized dose, combination, or format (such as sublingual troches or combination tablets with other active ingredients).

Price is the primary draw. Compounded vardenafil from 503A pharmacies in Montana can cost significantly less than retail generics, with some telehealth-linked compounding services offering monthly supplies at very low price points. The trade-off: compounded drugs are not FDA-approved products. They do not undergo the same bioequivalence testing as FDA-approved generics.

The FDA's guidance on 503A compounding requires that compounded drugs use bulk drug substances from FDA-registered facilities, that the pharmacy holds a valid state license, and that each prescription be patient-specific. Montana's Board of Pharmacy enforces these requirements.

Combination compounds, pairing vardenafil with agents like oxytocin or apomorphine, have grown popular through telehealth platforms. No large RCTs validate these combinations. Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a lead author on the AUA ED guideline, has noted: "Combination compounded ED therapies lack the rigorous pharmacokinetic and safety data we require from approved products. Patients should understand that efficacy claims for these combinations rest on clinical experience, not controlled trial evidence."

Men considering compounded vardenafil should confirm the pharmacy's 503A license through the Montana Board of Pharmacy database and ask whether the pharmacy participates in voluntary accreditation through PCAB (Pharmacy Compounding Accreditation Board).

Telehealth Prescribing of Vardenafil in Montana

Montana permits telehealth prescribing of vardenafil without geographic restriction. The state's telehealth parity law requires that private insurers cover telehealth visits at the same rate as in-person visits, removing a cost barrier for the initial consultation.

Several national telehealth platforms operate in Montana and prescribe vardenafil: Hims, Ro, and HealthRX among them. The typical telehealth visit costs $0 to $50, and some platforms bundle the consultation fee into the medication price. Montana's vast rural geography makes telehealth particularly relevant. A man in Miles City or Glasgow may live 100+ miles from the nearest urologist. Telehealth removes that barrier entirely.

Prescribers conducting telehealth visits for vardenafil in Montana must hold an active Montana medical license or practice under the Interstate Medical Licensure Compact, which Montana joined in 2017. This means out-of-state physicians with Compact licenses can legally prescribe vardenafil to Montana patients via telehealth.

The prescribing evaluation for vardenafil via telehealth follows the same clinical standards as in-person visits. The prescriber assesses cardiovascular risk (PDE5 inhibitors are contraindicated with nitrate medications), screens for anatomical causes of ED, and reviews medication interactions. A 2005 ACC/AHA consensus statement established that PDE5 inhibitors are safe in men with stable cardiovascular disease not taking nitrates, a guideline that telehealth prescribers in Montana follow.

How to Get the Cheapest Vardenafil in Montana

Multiple strategies can reduce vardenafil costs below the $120 average.

Generic substitution. Always request generic vardenafil rather than brand Levitra. The $230 price gap between brand ($350) and generic ($120) is the single largest savings lever.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare coupons frequently drop generic vardenafil below $50 for an 8-tablet fill at Montana chains like Albertsons, Walgreens, and Walmart. These coupons cannot be combined with insurance but often beat insured copays, especially for patients on high-deductible plans.

Manufacturer savings cards. Bayer's savings program for brand Levitra is largely irrelevant now that generics dominate the market, but several generic manufacturers offer copay assistance. Eligibility typically excludes government-insured patients (Medicaid, Medicare, Tricare).

Pill splitting. Vardenafil 20 mg tablets can be split to yield two 10 mg doses at roughly half the per-dose cost. The FDA label does not specifically address splitting, but the tablets are scored and clinicians commonly recommend this approach. Staxyn (the orally disintegrating tablet) cannot be split.

503A compounding. As discussed above, compounded vardenafil through telehealth-linked 503A pharmacies can reach the lowest price points available in Montana.

90-day fills. Mail-order pharmacies and some Montana retailers offer 90-day supplies at a per-tablet discount of 15% to 25% compared to 30-day fills.

Dr. Mohit Khera, Professor of Urology at Baylor College of Medicine, has stated: "Cost remains one of the most common reasons men discontinue PDE5 inhibitor therapy. Switching to generics and using pharmacy discount tools can make the difference between a patient staying on treatment versus stopping."

Vardenafil vs. Other PDE5 Inhibitors: Montana Cost Comparison

Montana men choosing between PDE5 inhibitors should weigh both cost and pharmacology.

Generic sildenafil is the cheapest option statewide, averaging $15 to $30 per month at Montana pharmacies. Generic tadalafil (daily 5 mg) runs $30 to $60 per month. Generic vardenafil sits at roughly $120 per month, making it the most expensive of the three common generics.

The clinical rationale for choosing vardenafil over cheaper alternatives comes down to tolerability and onset. The Porst et al. trial showed vardenafil's selectivity for PDE5 over PDE6 is roughly 15-fold higher than sildenafil's, which may explain the lower incidence of visual disturbances (blue-tinted vision) reported with vardenafil. A 2011 meta-analysis by Yuan et al. comparing PDE5 inhibitors found similar overall efficacy across the class but noted that individual response varies, supporting a trial-and-switch approach.

For men in Montana who have tried sildenafil and experienced bothersome side effects, the extra cost of vardenafil may be clinically justified. For treatment-naive patients without a specific reason to choose vardenafil, starting with generic sildenafil at $15 to $30 per month is the most cost-effective first step, consistent with the step-therapy protocols most Montana insurers already require.

Safety and Prescribing Considerations Specific to Montana

Montana's population health profile includes higher-than-average rates of cardiovascular disease and tobacco use compared to national medians, according to CDC BRFSS data. Both factors are relevant to vardenafil prescribing.

Vardenafil carries a black-box-level warning against concurrent nitrate use due to the risk of severe hypotension. Montana men using nitroglycerin for angina, isosorbide mononitrate, or isosorbide dinitrate must not take vardenafil. Alpha-blocker interactions also require dose adjustments. The FDA label recommends starting vardenafil at 5 mg when co-prescribed with alpha-blockers like tamsulosin or doxazosin.

QTc prolongation is a vardenafil-specific concern not shared by sildenafil or tadalafil. The FDA label notes a mean QTc increase of 8 ms at the 10 mg dose. Men with congenital long QT syndrome, those taking Class IA or Class III antiarrhythmics (quinidine, procainamide, amiodarone, sotalol), or those with baseline QTc >450 ms should avoid vardenafil entirely. This distinguishes vardenafil from its PDE5 inhibitor alternatives and is a factor Montana prescribers must weigh, particularly in older patients with cardiac histories.

Standard dosing: 10 mg taken 30 to 60 minutes before sexual activity, titrated to 5 mg or 20 mg based on efficacy and tolerability. Maximum frequency is once per 24 hours. Fatty meals delay absorption and reduce peak plasma concentration by approximately 18 to 50%, per the FDA label.